Ledger.Open graph →

SEC Form D · filed January 21, 2015

BRAINSTORM CELL THERAPEUTICS INC

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HACKENSACK, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Uri S. Yablonka · Hackensack, NJExec · Director Irit Arbel · Hackensack, NJDirector Chaim S. Lebovits · Hackensack, NJExec Malcolm S. Taub · Hackensack, NJDirector Mordechai S. Friedman · Hackensack, NJDirector Anthony S. Fiorino · NEW YORK, NYExec Alon Pinkas · Hackensack, NJDirector Irit Arbel · JERUSALEM, L3Director Liat Sossover · Hackensack, NJExec Chen Schor · Westminster, CODirector Robert Shorr · CRANBURY,, NJDirector Mordechai S. Friedman · Hackensack, NJDirector Anthony S. Fiorino · Hackensack, NJExec Alon Pinkas · Hackensack, NJDirector Uri S. Yablonka · NEW YORK, NYExec · Director Irit Arbel · Hackensack, NJDirector Liat Sossover · Hackensack, NJExec Chen Schor · Hackensack, NJDirector Chaim S. Lebovits · Hackensack, NJExec Robert Shorr · CRANBURY,, NJDirector Malcolm S. Taub · Hackensack, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗